Haem Flashcards

1
Q
Causes of a microcytic anaemia (low MCV)
vs 
Normocytic (normal MVC) 80-100
vs 
Microcytic
A

Microcytic anaemia (FAT)

1) Fe deficiency (low ferritin)
2) Anaemia of chronic disease e.g. RA. (normal/high ferritin)
3) Thalassaemia (alpha or beta)

Normocytic anaemia
Infection, inflammation, malignancy duh
- also anaemia of chronic disease
1) Anaemia of chronic disease, acute blood loss
2) Haemolysis, hypothyroid
3) Failure - BM (aplastic anaemia), Renal
4) Pregnancy

Macrocytic anaemia

1) Megaloblastic - folate/B12 deficiency
2) Non megaloblastic - Alcohol, Haemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Blood findings in Fe deficiency anaemia

Symptoms/signs

Treatment
including dose, duration and side effects

A
Low ferritin (iron storage)
High transferrin

Blood film: Microcytic, hypo chromic

  • Variation in size (anisocytosis)
  • Variation in shape (poikilocytosis)
  • Pencil cells

Signs

  • Pallor, lethargy, SOB
  • Atrophic glossitis; Angular stomatitis (cheilitis)
  • Koilonychia (spoon shaped nails)
  • Post cricoid webs (Plummer vinson syndrome)

Treatment
65 mg elemental iron (ferrous sulphate 200 mg) 3x daily
- Recheck Hb in 4 weeks (should go up by
- Continue at least 3 months after Hb normalises

Side effects of ferrous sulphate: Nausea, abdominal discomfort, diarrhoea or constipation, black stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Petechiae cause

Differential diagnosis

A

Thrombocytopenia (low platelets)

Leukaemia
Meningococcal septicaemia
Vasculitis
Henoch-Schonlein Purpura (HSP)
Idiopathic Thrombocytopenia Purpura (ITP)
Non-accidental injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

B12 deficiency

Causes

Clinical features

Investigations

A

Causes:
Low intake - vegan (found in meat, fish and dairy)
Low absorption - Pernicious anaemia (antibodies against IF/Parietal cells), Ilieal resection, Chron’s, bacterial overgrowth, tape worms

Importance of B12
B12 helps synthesize thymidine, and hence dna, so in deficiency RBC production is slow. Untreated, it can lead to megaloblastic anaemia and irreversible CNS complications

Clinical features

  • General: Jaundice (due to haemolysis), glossitis, angular stomatitis
  • Neuro: Irritability, depression, psychosis
  • Spinal cord degeneration: Paraesthesiae, peripheral neuropathy. Also subacute combined degeneration of the spinal cord, a combination of peripheral sensory neuropathy with both upper and lower motor neuron signs due to ↓b12. The patient may display the classical triad of:
    (1) Extensor plantars (UMN)
    (2) Loss of knee jerk (LMN)
    (3) Loss of ankle jerk (LMN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pernicious anaemia - what is it

Blood results

Management

A

Autoimmune condition in which atrophic glossitis –> lack of IF secretion from parietal cells of the stomach. Dietary B12 remains unbound and so can’t be absorbed in terminal ileum

Blood results

  • Microcytic anaemia
  • Low serum B12
  • Hypersegmented neutrophils (>5 losses) = megaloblastic anaemia
  • Parietal cell antibodies found in 90%
  • IF antibodies, specific for PA but lower sensitivity

Management (of B12 deficiency)

  • Treat the cause if possible
  • If due to malabsorption - IM Hydroxocobalamin (B12) 1mg IM alternate days for 2 weeks, then every 3 months for live
  • If due to poor oral intake: Oral B12 after the initial IM course (50-150mcg daily between meals)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is thalassaemia?

What is beta thalassaemia

Types of beta thalassaemia
- for the worst give signs, blood film, electrophoresis, treatment

A

Genetic diseases of unbalanced Hb synthesis, with underproduction (or no production) of one globin chain. Unmatched globing precipitate, damaging RBC membranes, causing their haemolysis while still in the marrow

Beta thalassaemia: Point mutations in beta globin genes on chromosome 11

1) Beta thalassaemia minor/trait (heterozygous trait)
- Usually asymptomatic
- Mild, well tolerated anaemia (Hb >90) - may worsen in pregnancy
- MCV <75, HbA2 >3.5%, slight increase in HbF

2) Beta thalassaemia intermedia
- Moderate anaemia but not requiring transfusion
- May be splenomegaly
- Causes: Mild homozygous mutations, co inheritance with another trait e.g. HbC thalassaemia

3) Beta thalassaemia major
- Significant abnormalities in both beta-globin genes
- Presents in 1st year: Severe anaemia + FTT
- Extra-medullar Haematopoesis: RBCs made outside marrow: Skull bossing + hepatosplenomegaly (due to haemolysis)
- Osteopenia
- Life long blood transfusions needed - iron overload seen in 10yrs as endocrine failure (pituitary, thyroid, pancreas –> DM), liver disease and cardiac toxicity
- Blood film: Hypochromic anaemia, Target cells, Increased reticulocyte count
- Hb electrophoresis: ⇈HbF, HbA2 variable, HbA absent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CLL

Staging system

Symptoms

Signs

Blood results

Disease progression

A

Rai staging
0Lymphocytosis alone
Median survival >13yrs

I Lymphocytosis + lymphadenopathy
Median survival 8yrs

IILymphocytosis + spleno- or hepatomegaly
Median survival 5yrs

III Lymphocytosis + anaemia (Hb <110g/L)
2yrs Median survival

IV Lymphocytosis + platelets <100 × 109/L
1yr Median survival

Symptoms
- Often non - surprise on routine FBC
- May have anaemia, infection prone, or weight loss/anorexia/night sweats if severe
Signs
- Enlarged rubbery lymph nodes
- Splenomegaly, hepatomegaly

Bloods
↑Lymphocytes—may be marked
Later: autoimmune haemolysis, marrow infiltration: ↓Hb, ↓neutrophils, ↓platelets.
Smear cells

Natural history - commonest leukaemia
⅓ never progress (or even regress), ⅓ progress slowly, and ⅓ progress actively. cd23 and β‎2 microglobulin correlate with bulk of disease and rates of progression. Death is often due to infection or transformation to aggressive lymphoma (Richter’s syndrome).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

differential for enlarged spleen

A
  1. enlarged left kidney; unless enormous, there is resonance over the swelling anteriorly as it is covered by the gas containing colon
  2. carcinoma of the cardio or upper part of the body of the stomach; by the time it’s this big they were usually symptoms of gastric obstruction
  3. enlarged left lobe of the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Classification for enlargement of the spleen

massive splenomegaly causes

A
1.infections
Dash viruses: glandular fever
Dash bacterial: Typhus, typhoid, septicemia
- Protozoa,: malaria, schistosomiasis
- Parasitic: Hydatid
  1. Hematological disease
    - leukemia: CML & CLL
    - lymphoma: Hodgkins and non-Hodgkin’s
    - Milo fibrosis, I TP, polycythemia rubra vera
    - Hemolytic anemia is: e.g. spherocytosis, beta thalassemia
  2. Portal hypertension
    Increased pressure in the portal system causes progressive enlargement spleen and may lead to hypersplenism [e.g. excess removal of platelets resulting in thrombocytopenia]
  3. Metabolic and collagen disease disease
    - Amyloid Secondary to our ARA, collagen disease, chronic sepsis
    - storage disease is e.g. Gaucher’s disease
  4. Cysts, abscesses and tumors of the spleen
    All uncommon
massive splenomegaly 
CML
Myelofibrosis
Lymphoma
Polycythemia
Portal hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Indications for splenectomy

complications

A
Indications
Rupture
Hematological disease 
Tumors insists
Part of another procedure e.g. radical excision of stomach cancer, distal pancreatectomy, splenorenal anastomosis For portal  hypertension

complications

  • Gastric dilation
  • Thrombocytosis: DVT and PE risk. Antiplatelets like aspirin are given a prophylaxis in addition to MMWH
  • Post splenectomy sepsis ( in capsulated microorganisms especially) - Immunization with Nakul, meningococcal an H influenza type B vaccines should be given preop. Adult should have penicillin for at least two years after splenectomy (Children get it until they are adults]. Annual flu vaccine also.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Howell-jolly bodies

What do they look like
Cause

A

Nuclear remnant in circulating erythrocytes

Hyposplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heinz bodies cause

Other things seen on blood film

A

G6PD deficiency

Irregularly contracted cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Schistocytes causes

A

MAHA

Prosthetic valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Target cells

What do they look like
Causes

A

Targets?

Hyposplenism
Thalassaemia
Liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pencil cells cause

A

Iron deficiency anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Basophilic stippling causes

A

Thalassaemia

Lead poisoning

17
Q

Reticulocytes causes

A

Haemolysis

Haemorrhage

18
Q

MM

PP

Features

Diagnosis

Investigations

Management

Prognosis

A

Epidemiology
M=F
~70yo

PP
Clonal plasma cell proliferation –> monoclonal Ig (IgA or IgG)
- Clones may produces light chains excreted by kidneys –> renal insufficiency
- Clones produce IL-6 which inhibits osteoblasts and activates osteoclasts

Features
Renal insufficiency
Hypercalcaemia 
Anaemia
Bone - vertebral collapse, path fracture, bone pain
Diagnosis
Clonal BM plasma cells >/= 10%
Presence of se/urinary monoclonal protein
End organ damage 
Calcium >2.6
Anaemia 10
Renal insufficiency
Bone involvement

Investigations
Urine - high specific gravity; Electrophoresis - BJP
FBC: Anaemia; ESR: high; Ca: high; ALP normal
Blood film: rouleaux cells +/- plasma cells +/- cytopaenias
Renal function
Bone profile - inc calcium
X-rays: Pepper pot skull, and as above, punched out lytic lesions
Trephine BM biopsy

Management
1) Supportive
Calcium: Hydrate, bisphosphates ?frusomide
Renal: Hydrate, dialyse
Anaemia: Transfuse, EPO
Bone: Bisphosphonates
Infections: Broad spectrum abx, ?IVIg

2) Specific - based on fitness
- fit: induction chemo then BMT
- Unfit: Chemo only

Prognosis
? not good
- Mean survival 3-5yrs

19
Q

Thrombophilia

A

High platelets

Causes

1) Inherited
- Factor V Leiden (APC)
- Prothrombin gene mutation
- Antithrombin 3 deficiency
- Protein C and protein S deficiency

2) Acquired
- Anti-phospholipid syndrome

Presentation
Recurrent embolisms
- Arterial thrombosis
- Venous thrombosis
ETC
Investigations
Thrombophilia screen
- FBC, Clotting, fibrinogen leve;ls
- FV leiden/APC resistance
- Assays for AT, Protein C and protein S deficiency
- Genertics
- Electrophoresis
- Lupus anticoagulant, anti-cardiolipin antibodies

Management

  • Warfarin target INR 2-3, If recurs on warfarin target INR 3-4
  • Don’t need lifelong anticoagulation if asymptomatic
  • Rx acute thrombosis as per normal
20
Q

Myelodysplastic syndrome

Cause

Investigations

Presentation

Management

A

Heterogenous group of conditions –> BM failure

Cause
Primary
Secondary: Chemo/radiotherapy

Investigations
Bone marrow tap: Hypercellular, blasts, ringed sideroblasts
FIlm: Peglet huer anomaly, blasts
Pancytopaenia

Presentation
No splenomegaly
Infections, Anaemia, Bleeding/Bruising

Management
Supportive: Transfusions, EPO, G-CSF
Immunosuppression
BM Transplant

21
Q

Hodgkins lymphoma

Presentation

Epidemiology

Investigations

Management

A

Presentation

  • Painless asymmetric lymphadenopathy, pain on alcohol, spreads contiguously from node to node
  • EBV associated
  • Cervical lymph nodes in 70%
  • B symptoms
  • Hepatosplenomegaly

Epidemiology
- YA and elderly = bimodal

Investigations

  • LN biopsy: Reed stein berg cells
  • CT/MRI CAP: Ann Arbor staging - remember B symptoms

Management

  • ABVD
  • BMT for relapse
22
Q

HUS

A

Cause
E.coli

Presentation

  • MAHA: Shcistocytes, low plateletss, normal clotting
  • Thrombocytopaenia
  • AKI

Management
- Supportive, resolves spontaneously; may need transfusion or dialysis

23
Q

SCD

PP

Presentation

Investigations

Complications

Management

A

PP
Point mutation in beta globin gene glu–> val causes HbS vs HbA
HbS - prone to sickling when deoxygenated
–> thrombosis by occluding microvasculature
–> haemolysis as reduced life span
HbSS = SCA, HbSA = trait

Investigations:
Blood film
Hb electrophoresis

Triggers: Cold, infection, stress, hypoxic, dehydration

Presentation: SICKLED
Splenomegaly may --> sequestration crises
Infarctions - spleen
Crises: Pulmonary, mesenteric - (vaso-occlusive, sequestration, aplastic)
Kidney disease
Liver, Lung disease
ERECTION
Dactylitis 
Complications
Aplastic anaemia --> parvovirus B19
Infections --> osteomyelitis 
Gallstones (DUH)
Splenic sequestration
Splenic infarction 

Management
Chronic: Folate, Immunisations
Crises: Analgesia (opioids), oxygen, exchange transfusion, Abx e.g. ceftriaxone if necessary

24
Q

Vascular/ platelets disorder vs coagulation disorder features

A

Vascular disorders/Platelet disorders
– bleeding into skin
– Bleeding mucus membranes, immediate, prolonged bleeding from cut

Coagulation disorder
– Deep bleeding: muscles, joints, tissues
– Delayed but severe bleeding after injury

25
Q

Polycythaemia vera

Features

Investigations

Management

Prognosis

A

99% JAK2 +ve

Features
Hyperviscosity
- Headache, tinnitus, flushing
Histamine release
- Aquagenic pruritus
- Splenomegaly
- Hepatomegaly

Investigations -
High Hb, High Hct
JAK2

Management

  • Aspirin aim for Hct <0.45
  • Venesection if needed/young; Hydroxycarbamide if older/highrisl

Prognosis
30% –> MF
5% –> AML

26
Q

Tumour lysis syndrome

Electrolyte abnormalities

A
hyperkalaemia
hyperphosphataemia
hyperuricaemia
hypocalcaemia
acute renal failure
27
Q

G6PD deficiency

A

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest red blood cell enzyme defect. It is more common in people from the Mediterranean and Africa and is inherited in an X-linked recessive fashion. Many drugs can precipitate a crisis as well as infections and broad (fava) beans

Pathophysiology
↓ G6PD → ↓ glutathione → increased red cell susceptibility to oxidative stress

Features
neonatal jaundice is often seen
intravascular haemolysis
gallstones are common
splenomegaly may be present
Heinz bodies on blood films. Bite and blister cells may also be seen

Diagnosis is made by using a G6PD enzyme assay

Some drugs causing haemolysis
anti-malarials: primaquine
ciprofloxacin
sulph- group drugs: sulphonamides, sulphasalazine, sulfonylureas

Some drugs thought to be safe
penicillins
cephalosporins
macrolides
tetracyclines
trimethoprim
28
Q

AIHA

A

Autoimmune haemolytic anaemia (AIHA) may be divided in to ‘warm’ and ‘cold’ types, according to at what temperature the antibodies best cause haemolysis. It is most commonly idiopathic but may be secondary to a lymphoproliferative disorder, infection or drugs. AIHA is characterised by a positive direct antiglobulin test (Coombs’ test)

Warm AIHA

In warm AIHA the antibody (usually IgG) causes haemolysis best at body temperature and haemolysis tends to occur in extravascular sites, for example the spleen. Management options include steroids, immunosuppression and splenectomy

Causes of warm AIHA
autoimmune disease: e.g. systemic lupus erythematosus*
neoplasia: e.g. lymphoma, CLL
drugs: e.g. methyldopa

Cold AIHA

The antibody in cold AIHA is usually IgM and causes haemolysis best at 4 deg C. Haemolysis is mediated by complement and is more commonly intravascular. Features may include symptoms of Raynaud’s and acrocynaosis. Patients respond less well to steroids

Causes of cold AIHA

neoplasia: e.g. lymphoma
infections: e.g. mycoplasma, EBV

29
Q

What is Waldenstrom’s macroglobulinaemia

Features

A

Waldenstrom’s macroglobulinaemia is an uncommon condition seen in older men. It is a lymphoplasmacytoid malignancy characterised by the secretion of a monoclonal IgM paraprotein

Features
monoclonal IgM paraproteinaemia
systemic upset: weight loss, lethargy
hyperviscosity syndrome e.g. visual disturbance
the pentameric configuration of IgM increases serum viscosity
hepatosplenomegaly
lymphadenopathy
cryoglobulinaemia e.g. Raynaud's
30
Q

Dabigatran

MOA

Reversal

Excretion

A

Dabigatran is a new oral anticoagulant, used in this case to prevent another venous thromboembolic episode.

Dabigatran is a direct thrombin inhibitor.

Unlike other NOACs, dabigatran has an antidote i.e. Idarucizumab. Idarucizumab is a humanised monoclonal antibody that directly inhibits dabigatran.

Excretion = renal

31
Q

Cryoprecipitate

Composition

Use

A
Composition
Factor VIII	100IU
Fibrinogen	250mg
von Willebrand factor	Variable
Factor XIII	Variable

Use
Blood product made from plasma
Usually transfused as 6 unit pool
Indications include massive haemorrhage and uncontrolled bleeding due to haemophilia

32
Q

Neutropenic sepsis

Dx

Prophylaxis

Management

A

Neutropenic sepsis is a relatively common complication of cancer therapy, usually as a consequence of chemotherapy. It most commonly occurs 7-14 days after chemotherapy. It may be defined as a neutrophil count of < 0.5 * 109 in a patient who is having anticancer treatment and has one of the following:
a temperature higher than 38ºC or
other signs or symptoms consistent with clinically significant sepsis

Prophylaxis
if it is anticipated that patients are likely to have a neutrophil count of < 0.5 * 109 as a consequence of their treatment they should be offered a fluoroquinolone

Management
antibiotics must be started immediately, do not wait for the WBC
NICE recommend starting empirical antibiotic therapy with piperacillin with tazobactam (Tazocin) immediately
many units add vancomycin if the patient has central venous access but NICE do not support this approach
following this initial treatment patients are usually assessed by a specialist and risk-stratified to see if they may be able to have outpatient treatment
if patients are still febrile and unwell after 48 hours an alternative antibiotic such as meropenem is often prescribed +/- vancomycin
if patients are not responding after 4-6 days the Christie guidelines suggest ordering investigations for fungal infections (e.g. HRCT), rather than just starting therapy antifungal therapy blindly
there may be a role for G-CSF in selected patients

33
Q

Negative prognostic features for Hodgkins Lymphoma

A

The presence of B symptoms (night sweats, weight loss and fever)
Male gender
Being aged >45 years old at diagnosis
High WCC, low Hb, high ESR or low blood albumin

34
Q

Sickle cell anaemia mangement

A

Crisis management
analgesia e.g. opiates
rehydrate
oxygen
consider antibiotics if evidence of infection
blood transfusion
exchange transfusion: e.g. if neurological complications

Longer-term management
hydroxyurea
increases the HbF levels and is used in the prophylactic management of sickle cell anaemia to prevent painful episodes
NICE CKS suggest that sickle cell patients should receive the pneumococcal polysaccharide vaccine every 5 years

35
Q

CLL Complication

A

Complications
anaemia
hypogammaglobulinaemia leading to recurrent infections
warm autoimmune haemolytic anaemia in 10-15% of patients
transformation to high-grade lymphoma (Richter’s transformation)

Richter’s transformation

Ritcher’s transformation occurs when leukaemia cells enter the lymph node and change into a high-grade, fast-growing non-Hodgkin’s lymphoma. Patients often become unwell very suddenly.

Ritcher's transformation is indicated by one of the following symptoms: 
lymph node swelling
fever without infection
weight loss
night sweats
nausea
abdominal pain
36
Q

Blood cell transfusion threshold

A

Patients without ACS Patients with ACS
Transfusion threshold 70 g/L 80 g/L
Target after transfusion 70-90 g/L 80-100 g/L

37
Q

Platelet transfusion criteria

A

Active bleeding

Offer platelet transfusions to patients with a platelet count of <30 x 10 9 with clinically significant bleeding (World Health organisation bleeding grade 2- e.g. haematemesis, melaena, prolonged epistaxis)

Platelet thresholds for transfusion are higher (maximum < 100 x 10 9) for patients with severe bleeding (World Health organisation bleeding grades 3&4), or bleeding at critical sites, such as the CNS.

It should be noted that platelet transfusions have the highest risk of bacterial contamination compared to other types of blood product.

Pre-invasive procedure (prophylactic)

Platelet transfusion for thrombocytopenia before surgery/ an invasive procedure. Aim for plt levels of:
> 50×109/L for most patients
50-75×109/L if high risk of bleeding
>100×109/L if surgery at critical site

If no active bleeding or planned invasive procedure

A threshold of 10 x 109 except where platelet transfusion is contradindicated or there are alternative treatments for their condition

For example, do not perform platelet transfusion for any of the following conditions:
Chronic bone marrow failure
Autoimmune thrombocytopenia
Heparin-induced thrombocytopenia, or
Thrombotic thrombocytopenic purpura.